Lucid s quarterly revenue increased 392 percent sequentially
Veris Health commercial expansion efforts underway, with next-generation Veris Cancer Care Platform launching in Q4
Conference call and.
Conference Call and Webcast at 8:30 AM Eastern Time
NEW YORK, Nov. 1, 2023 /PRNewswire/ PAVmed Inc. , a diversified commercial-stage medical technology company, operating in the medical.
EsoGuard® test volume continues to grow as Lucid makes strides with commercial expansion and additional supporting data
Veris Health prepares to launch the next generation of the Veris Cancer Care. -Today at 08:19 pm- MarketScreener
PAVmed (PAVM) Reports Q2, Provides Business Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the.